|
|
 |
|
|
|
|
|
The Protamine Advantage
Cardiva Catalyst III expands beyond Cardiva Catalyst II technology
with the addition of a protamine sulfate coating. In heparinized
patients, this coating acts to locally neutralize heparin and further
aid the body's natural hemostatic process.
|
|
|
|
|
|
|
Mechanism of Action: The Body's Response
|
|
|
|
Cardiva Catalyst III supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition, and coagulation.
|
|
|
| |
|
|
|
|
Natural Elastic Recoil
|
|
|
|
The smooth muscle of the artery relaxes to a pre-dilated state the size of an 18 gauge needle stick.
|
|
|
 |
|
| |
|
|
|
|
Tissue apposition
|
|
|
|
Optimized tissue apposition facilitates vessel healing.
|
|
|
 |
|
| |
|
|
|
|
Localized protamine
|
|
|
|
The application of the localized protamine sulfate is designed to neutralize the effects of heparin in the tissue tract at the puncture site.
|
|
|
 |
|
| |
|
|
|
|
Coagulation
|
|
|
|
The proprietary Catalyst hemostatic coating stimulates both the intrinsic and extrinsic pathways of the coagulation cascade forming fibrin, the backbone of the clot.
|
|
|
 |
|
|
|
|
|
|
|
|
|
